Glucose disposal rate test for fatty liver diagnosis
Part of Hormones & metabolism clinical trials.
This study looks at a new way to check how well your body handles sugar (glucose disposal rate) to detect fatty liver linked to metabolic syndrome. It may help doctors diagnose this condition more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have metabolic syndrome (belly fat plus at least two of: high triglycerides, low good cholesterol, high blood pressure, or high blood sugar).
- You do not have other liver diseases like hepatitis.
- You drink little or no alcohol (less than 2 drinks/day for men, 1 drink/day for women).
- You are not pregnant, do not have active cancer or advanced liver scarring, and do not take steroids or similar drugs affecting metabolism.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital health app designed to help people with metabolic-associated fatty liver disease (MAFLD). The app provides diet and exercise guidance to improve liver health.
This study classifies fatty liver disease (MAFLD) by examining liver tissue samples. It aims to better understand how metabolic risk factors like high blood sugar, high blood pressure, or excess weight relate to the liver's condition.
This trial is testing a new ultrasound method to measure fat in the liver for people with metabolic fatty liver disease (MAFLD). It may help understand how well ultrasound can show liver fat compared to a liver biopsy or MRI.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study compares new, non-invasive tests to standard liver biopsy for diagnosing fatty liver disease in people with type 2 diabetes or other signs of metabolic syndrome. It aims to see if these simpler tests can replace biopsies.
This study looks at whether a simple blood test combined with your weight can help find fatty liver disease in people with metabolic syndrome. It may offer an easier way to check liver health without more invasive tests.
Hear when a new MAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.